275 related articles for article (PubMed ID: 29968697)
1. How and when to measure anticoagulant effects of direct oral anticoagulants? Practical issues.
Tripodi A; Braham S; Scimeca B; Moia M; Peyvandi F
Pol Arch Intern Med; 2018 Jun; 128(6):379-385. PubMed ID: 29968697
[TBL] [Abstract][Full Text] [Related]
2. Laboratory testing for lupus anticoagulant (LA) in patients taking direct oral anticoagulants (DOACs): potential for false positives and false negatives.
Favaloro EJ; Mohammed S; Curnow J; Pasalic L
Pathology; 2019 Apr; 51(3):292-300. PubMed ID: 30665674
[TBL] [Abstract][Full Text] [Related]
3. Emergency Coagulation Assessment During Treatment With Direct Oral Anticoagulants: Limitations and Solutions.
Ebner M; Birschmann I; Peter A; Härtig F; Spencer C; Kuhn J; Blumenstock G; Zuern CS; Ziemann U; Poli S
Stroke; 2017 Sep; 48(9):2457-2463. PubMed ID: 28775134
[TBL] [Abstract][Full Text] [Related]
4. Point-of-care testing for emergency assessment of coagulation in patients treated with direct oral anticoagulants.
Ebner M; Birschmann I; Peter A; Spencer C; Härtig F; Kuhn J; Blumenstock G; Zuern CS; Ziemann U; Poli S
Crit Care; 2017 Feb; 21(1):32. PubMed ID: 28196509
[TBL] [Abstract][Full Text] [Related]
5. Measurement and reversal of the direct oral anticoagulants.
Samuelson BT; Cuker A
Blood Rev; 2017 Jan; 31(1):77-84. PubMed ID: 27625113
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the effect of the anti-Xa direct oral anticoagulants apixaban, edoxaban, and rivaroxaban on coagulation assays.
Gosselin R; Grant RP; Adcock DM
Int J Lab Hematol; 2016 Oct; 38(5):505-13. PubMed ID: 27265752
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of DOAC Filter, a new device to remove direct oral anticoagulants from plasma samples.
Sevenet PO; Cucini V; Hervé T; Depasse F; Carlo A; Contant G; Mathieu O
Int J Lab Hematol; 2020 Oct; 42(5):636-642. PubMed ID: 32567799
[TBL] [Abstract][Full Text] [Related]
8. Screening test for direct oral anticoagulants with the dilute Russell viper venom time.
Pratt J; Crispin P
Eur J Haematol; 2018 Jun; 100(6):567-574. PubMed ID: 29486103
[TBL] [Abstract][Full Text] [Related]
9. Laboratory and Clinical Monitoring of Direct Acting Oral Anticoagulants: What Clinicians Need to Know.
Conway SE; Hwang AY; Ponte CD; Gums JG
Pharmacotherapy; 2017 Feb; 37(2):236-248. PubMed ID: 27983747
[TBL] [Abstract][Full Text] [Related]
10. Reversal agents for direct oral anticoagulants: considerations for hospital physicians and intensivists.
Desai NR; Cornutt D
Hosp Pract (1995); 2019 Aug; 47(3):113-122. PubMed ID: 31317796
[TBL] [Abstract][Full Text] [Related]
11. Management of major bleeding complications and emergency surgery in patients on long-term treatment with direct oral anticoagulants, thrombin or factor-Xa inhibitors: proposals of the working group on perioperative haemostasis (GIHP) - March 2013.
Pernod G; Albaladejo P; Godier A; Samama CM; Susen S; Gruel Y; Blais N; Fontana P; Cohen A; Llau JV; Rosencher N; Schved JF; de Maistre E; Samama MM; Mismetti P; Sié P;
Arch Cardiovasc Dis; 2013; 106(6-7):382-93. PubMed ID: 23810130
[TBL] [Abstract][Full Text] [Related]
12. Direct oral anticoagulants and heparins: laboratory values and pitfalls in 'bridging therapy'.
Eller T; Flieder T; Fox V; Gripp T; Dittrich M; Kuhn J; Alban S; Knabbe C; Birschmann I
Eur J Cardiothorac Surg; 2017 Apr; 51(4):624-632. PubMed ID: 28043992
[TBL] [Abstract][Full Text] [Related]
13. Detection of lupus anticoagulant in the era of direct oral anticoagulants.
Hoxha A; Banzato A; Ruffatti A; Pengo V
Autoimmun Rev; 2017 Feb; 16(2):173-178. PubMed ID: 27988438
[TBL] [Abstract][Full Text] [Related]
14. Recent guidelines and recommendations for laboratory assessment of the direct oral anticoagulants (DOACs): is there consensus?
Lippi G; Favaloro EJ
Clin Chem Lab Med; 2015 Feb; 53(2):185-97. PubMed ID: 25241734
[TBL] [Abstract][Full Text] [Related]
15. Laboratory measurement of the direct oral anticoagulants.
Dale BJ; Chan NC; Eikelboom JW
Br J Haematol; 2016 Feb; 172(3):315-36. PubMed ID: 26492202
[TBL] [Abstract][Full Text] [Related]
16. [Laboratory coagulation tests in patients treated by direct oral anticoagulants (DOACs)].
Sié P
Presse Med; 2015; 44(7-8):772-8. PubMed ID: 26248706
[TBL] [Abstract][Full Text] [Related]
17. Interlaboratory Performance in Measurement of Dabigatran and Rivaroxaban.
Volod O; Rollins-Raval M; Goodwin AJ; Higgins RA; Long T; Chandler WL; Harris NS; Pham HP; Isom JA; Moser K; Olson JD; Smock KJ; VanSandt A; Wool G; Chen D
Arch Pathol Lab Med; 2022 Jan; 146(2):145-153. PubMed ID: 34133726
[TBL] [Abstract][Full Text] [Related]
18. Direct oral anticoagulants: new drugs and new concepts.
Levy JH; Spyropoulos AC; Samama CM; Douketis J
JACC Cardiovasc Interv; 2014 Dec; 7(12):1333-51. PubMed ID: 25523529
[TBL] [Abstract][Full Text] [Related]
19. Reversal of direct oral anticoagulants: a practical approach.
Shih AW; Crowther MA
Hematology Am Soc Hematol Educ Program; 2016 Dec; 2016(1):612-619. PubMed ID: 27913536
[TBL] [Abstract][Full Text] [Related]
20. Direct oral anticoagulant monitoring: what laboratory tests are available to guide us?
Sarode R
Hematology Am Soc Hematol Educ Program; 2019 Dec; 2019(1):194-197. PubMed ID: 31808890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]